MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025)

MapLight Therapeutics (MPLT) reported Amortizatization of Intangibles of $1.4 million for Q4 2025, up 252.57% on a YoY basis from $409000.0 in Q4 2024, and up 252.57% sequentially from $409000.0 in Q4 2024.

MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

MapLight Therapeutics (MPLT) has 2 years of Amortizatization of Intangibles data on file, last reported at $1.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 MapLight Therapeutics 88.50 Mn 88.50 Mn - 1.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.44 Mn
Dec 31, 2025 1.44 Mn
Dec 31, 2024 409,000.00
Dec 31, 2024 409,000.00